reference/8605644

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/8605644

Outgoing Links

Predicate	Object
contentType	Journal Article\|Multicenter Study\|Randomized Controlled Trial\|Research Support, Non-U.S. Gov't
endingPage	512
issn	0149-2918
issueIdentifier	3
pageRange	499-512
publicationName	Clinical Therapeutics
startingPage	499
bibliographicCitation	Covington P, Christopher R, Davenport M, Fleck P, Mekki QA, Wann ER, Karim A. Pharmacokinetic, pharmacodynamic, and tolerability profiles of the dipeptidyl peptidase-4 inhibitor alogliptin: a randomized, double-blind, placebo-controlled, multiple-dose study in adult patients with type 2 diabetes. Clin Ther. 2008 Mar;30(3):499–512. doi: 10.1016/j.clinthera.2008.03.004. PMID: 18405788.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7ea7fe3fbe1451459df52cef43b6cd54 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a7c7740c6b46f1c94d97f1061bfb24c7 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8fd855899a01e4d5b73db0da8ee27cda http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9f7e990549b7153965ee9386fcb79b36 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6560ee2ac2c651370695d66a9d914fae http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ca560eecde6cd024efde46ffc6546d69 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2d8d123b72d435dc3ba491ce82372261
date	200803
identifier	https://doi.org/10.1016/j.clinthera.2008.03.004 https://pubmed.ncbi.nlm.nih.gov/18405788
isPartOf	https://portal.issn.org/resource/ISSN/0149-2918 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/2822
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/
title	Pharmacokinetic, pharmacodynamic, and tolerability profiles of the dipeptidyl peptidase-4 inhibitor alogliptin: A randomized, double-blind, placebo-controlled, multiple-dose study in adult patients with type 2 diabetes
discusses	http://id.nlm.nih.gov/mesh/M0511100 http://id.nlm.nih.gov/mesh/M0003121 http://id.nlm.nih.gov/mesh/M0011417 http://id.nlm.nih.gov/mesh/M0010114 http://id.nlm.nih.gov/mesh/M0002696 http://id.nlm.nih.gov/mesh/M0508515 http://id.nlm.nih.gov/mesh/M0022302 http://id.nlm.nih.gov/mesh/M0028699 http://id.nlm.nih.gov/mesh/M0016932 http://id.nlm.nih.gov/mesh/M0016885
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_fa5fc799a3f3c6277beeb3473c262800 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11449 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_cdf1e220d89c2dcd2e000c3d105bf93e http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5793 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7907 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11450633 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_55029e08d2afcf59a719caf55a149021 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7333 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID20484 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7444 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_3389c62ce3a8d167b2a3c05ee87c671a http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7483

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID244648029 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129621433 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128212147 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID175427056

Total number of triples: 50.